CLINICAL_TRIALS
trial_result
· 2025-07-23
Clinical Trial Update: A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis [Phase 3]
Summary
Phase 3 clinical trial update for Nipocalimab in adults with generalized myasthenia gravis; the study is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Myasthenia Gravis | Phase 3 | Status: RECRUITING | Results posted: 2025-07-23